Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

February 5, 2021

Primary Completion Date

March 11, 2022

Study Completion Date

April 22, 2022

Conditions
Pouchitis
Interventions
DRUG

AMT-101 (oral)-Dose A

AMT-101 is an orally administered biologic therapeutic, taken once daily.

DRUG

AMT-101 (oral)-Dose B

AMT-101 is an orally administered biologic therapeutic, taken once daily.

Trial Locations (34)

1083

Semmelweis Egyetem I. sz Belgyogyaszati Klinika, Budapest

20815

Chevy Chase Clinical Research, Chevy Chase

24105

UKSH Universitätsklinikum Schleswig-Holstein, Kiel

27514

University of North Carolina GI, Chapel Hill

31059

CHU de Toulouse - Hôpital Rangueil, Toulouse

37232

Vanderbilt University Medical Center, Nashville

37909

Gastrointestinal Asssociates- GIA Clinical Trials, LLC, Knoxville

38138

Gastro One, Germantown

39232

Gastrointestinal Associates - Jackson, Flowood

42270

CHU Saint Etienne - Hopital Nord, Saint-Priest-en-Jarez

46026

Hospital Universitario y Politecnico La Fe de Valencia, Valencia

54511

CHRU Nancy - Hopital de Brabois, Vandœuvre-lès-Nancy

55905

Mayo Clinic, Rochester

60637

University of Chicago Medical Center, Chicago

75701

Tyler Research Institute, LLC, Tyler

84132

University of Utah Health Sciences Center, Salt Lake City

98405

Washington Gastroenterology, Tacoma, Tacoma

06010

Connecticut Clinical Research Institute, Bristol

Unknown

UZ Leuven - University Hospital Gasthuisberg, Leuven

Groupe santé CHC / Clinique du MontLégia, Liege, Liège

CHU de Rennes - Hopital de Pontchaillou, Rennes

Klinik für Innere Medizin KIM IV, Jena

University Hospital Tübingen, Tübingen

Szegedi Tudomanyegyetem Altalanos Orvostudomanyi Kar, Szeged

ETZ - Elisabeth, Tilburg

Clarunis Bauchzentrum, Basel

University Hospital of Zürich, Zurich

V6Z 2K5

GI Research Institute, Vancouver

D-10825

Praxis fur Gastroenterologie am Bayerischen Platz, Berlin

FY2 0JH

MAC Clinical Research - Blackpool, Blackpool

L34 1BH

MAC Clinical Research - Liverpool, Prescot

WS11 0BN

MAC Clinical Research - Cannock, Cannock

LS10 1DU

MAC Clinical Research - Leeds, Leeds

M13 9NQ

MAC Clinical Research - Manchester, Manchester

Sponsors
All Listed Sponsors
lead

Applied Molecular Transport

INDUSTRY

NCT04741087 - Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis | Biotech Hunter | Biotech Hunter